Provided by Tiger Trade Technology Pte. Ltd.

KALA BIO

0.4028
+0.02286.00%
Volume:127.69K
Turnover:51.18K
Market Cap:366.95M
PE:-0.07
High:0.4151
Open:0.3997
Low:0.3914
Close:0.3800
52wk High:20.60
52wk Low:0.3528
Shares:911.00M
Float Shares:911.00M
Volume Ratio:0.19
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8254
EPS(LYR):-10.1450
ROE:-708.34%
ROA:-65.81%
PB:-42.35
PE(LYR):-0.04

Loading ...

Kala Bio Inc. Files Initial Statement of Beneficial Ownership for Director Yonatan C. Colman

Reuters
·
Feb 10

Kala Bio Inc. ernennt Avi Minkowitz zum CEO und CFO

Reuters
·
Feb 06

KALA BIO Inc - Avi Minkowitz Appointed as CEO and CFO of KALA BIO - SEC Filing

THOMSON REUTERS
·
Feb 06

KALA BIO Inc - David Lazar Resigns as CEO and CFO of KALA BIO - SEC Filing

THOMSON REUTERS
·
Feb 06

Kala Bio Receives Nasdaq Warning Over Minimum Bid Price Compliance

Reuters
·
Jan 26

KALA BIO Receives Nasdaq Notice on Listing Compliance

TIPRANKS
·
Jan 24

KALA BIO Inc - on Jan 8, Enters Agreement With H.c. Wainwright - SEC Filing

THOMSON REUTERS
·
Jan 09

KALA BIO Launches At-the-Market Equity Offering Program

TIPRANKS
·
Jan 09

BRIEF-Kala Bio Settles Approximately $10.6 Million Of Debt

Reuters
·
Jan 06

Kala Bio Settles $10.6 Million Debt with Oxford Finance

Reuters
·
Jan 06

KALA BIO Settles Approximately $10.6 Million of Debt

THOMSON REUTERS
·
Jan 06

KALA BIO Inc - Pays $2 Mln to Oxford Finance Llc as Part of Settlement Agreement, Settles All Obligations - SEC Filing

THOMSON REUTERS
·
Jan 03

Kala Bio Inc. Settles $10.6 Million Debt with $2 Million Payment to Oxford Finance

Reuters
·
Jan 03

Kala Bio Inc. Announces Date for 2025 Annual Meeting of Stockholders

Reuters
·
Dec 31, 2025

Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading?

Benzinga_recent_news
·
Dec 24, 2025

KALA BIO Raises $10 Million From Direct Offering

MT Newswires Live
·
Dec 06, 2025

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:45 AM

Reuters
·
Dec 04, 2025

KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Dec 04, 2025

KALA BIO Inc - Purchase Price Set at $1.00 per Share in Direct Offering

THOMSON REUTERS
·
Dec 04, 2025

Press Release: KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Dow Jones
·
Dec 04, 2025